Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association.
about
Monotherapy in Patients with Type 2 Diabetes Mellitus.Monotherapy in patients with type 2 diabetes mellitus.Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017.Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association.Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017
P2860
Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association.
description
2017 nî lūn-bûn
@nan
2017 թվականի հոկտեմբերին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
name
Antihyperglycemic Agent Therap ...... e Korean Diabetes Association.
@en
Antihyperglycemic Agent Therap ...... e Korean Diabetes Association.
@nl
type
label
Antihyperglycemic Agent Therap ...... e Korean Diabetes Association.
@en
Antihyperglycemic Agent Therap ...... e Korean Diabetes Association.
@nl
prefLabel
Antihyperglycemic Agent Therap ...... e Korean Diabetes Association.
@en
Antihyperglycemic Agent Therap ...... e Korean Diabetes Association.
@nl
P2093
P2860
P1476
Antihyperglycemic Agent Therap ...... e Korean Diabetes Association.
@en
P2093
Byung Wan Lee
Committee of Clinical Practice Guideline of Korean Diabetes Association
Hyun Jin Kim
Jin Hwa Kim
Kyu Yeon Hur
Min Kyong Moon
Nan Hee Kim
Seok O Park
Seung Hyun Ko
P2860
P304
P356
10.4093/DMJ.2017.41.5.337
P577
2017-10-01T00:00:00Z